What laboratory tests should be ordered to evaluate anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Evaluation of Anemia

Order a complete blood count with differential, reticulocyte count, and iron studies (ferritin and transferrin saturation) as your core initial panel for any patient with suspected anemia. 1

Essential First-Line Tests

  • Hemoglobin measurement is superior to hematocrit because it demonstrates better inter-laboratory reproducibility, lower coefficient of variation, and remains unaffected by sample storage time or serum glucose levels. 1

  • Complete blood count with differential—including white blood cell and platelet counts—must be obtained to assess overall bone marrow function; abnormalities in two or more cell lines warrant immediate hematology referral for possible marrow pathology. 1

  • Mean corpuscular volume (MCV) directs your diagnostic pathway algorithmically:

    • Low MCV (<80 fL): pursue iron deficiency, thalassemia, or hemoglobin synthesis disorders 1
    • Normal MCV (80-100 fL): evaluate for anemia of chronic disease, hemolysis, or marrow disorders 1
    • High MCV (>100 fL): order vitamin B12, folate, and thyroid function tests 1

Reticulocyte Count: Assessing Marrow Response

  • Absolute reticulocyte count or reticulocyte index (adjusted for anemia severity) differentiates production failure from increased red cell loss or destruction. 1

  • Low reticulocyte count indicates inadequate marrow output from iron deficiency, intrinsic red cell production defects, insufficient erythropoietin (especially in chronic kidney disease), or inflammatory inhibition. 1

  • Elevated reticulocyte count signals active hemolysis or acute blood loss—immediately add lactate dehydrogenase, haptoglobin, bilirubin, and peripheral smear to your workup. 1

Iron Studies: Interpretation Framework

  • Serum ferritin serves as your surrogate marker for tissue iron stores and is essential in the initial iron panel. 1

  • Ferritin thresholds vary by clinical context:

    • General population: <45 ng/mL indicates iron deficiency when clinical context supports it 1
    • Non-dialysis CKD males: <25 ng/mL predicts insufficient iron stores 1
    • Non-dialysis CKD females: <11 ng/mL predicts insufficient iron stores 1
  • Transferrin saturation (TSAT) reflects iron immediately available for erythropoiesis and is less affected by inflammation, making it more reliable than ferritin in chronic kidney disease and inflammatory conditions. 1

Critical Pitfall: Ferritin as an Acute-Phase Reactant

  • Never interpret ferritin in isolation in patients with inflammation, chronic kidney disease, or chronic disease—ferritin can be falsely elevated in these settings, masking true iron deficiency. 1

  • In inflammatory states, prioritize TSAT over ferritin as your primary marker of iron availability for erythropoiesis. 1

Context-Specific Additional Testing

  • Peripheral blood smear provides morphologic clues when CBC and reticulocyte data are inconclusive, identifying specific anemia subtypes. 1, 2

  • For iron deficiency without obvious blood loss (excluding menstrual loss):

    • Begin with non-invasive testing for Helicobacter pylori and celiac disease 1
    • Proceed to bidirectional endoscopy (upper and lower) in males and post-menopausal females 1
    • In non-dialysis CKD patients receiving erythropoiesis-stimulating agents, actively investigate occult gastrointestinal bleeding 1
  • For macrocytic anemia (high MCV): order vitamin B12, folate, and thyroid function tests. 1

  • For microcytic anemia unresponsive to iron therapy: obtain hemoglobin electrophoresis, especially in individuals of Mediterranean, African, or Southeast Asian ancestry to evaluate for thalassemia. 1

Key Clinical Pitfalls to Avoid

  • A normal or low reticulocyte count in the presence of anemia is always abnormal—it indicates inadequate marrow response from erythropoietin deficiency, iron unavailability, or marrow suppression by inflammation or pathology. 1

  • In chronic kidney disease, do not automatically attribute anemia to CKD alone—the anemia of CKD is typically normochromic and normocytic, and comprehensive evaluation is required to exclude other etiologies. 1

  • When combining ferritin and TSAT in CKD or inflammatory conditions, interpret both together—relying on ferritin alone will misclassify iron status in these populations. 1

References

Guideline

Laboratory Evaluation of Anemia in Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Anemia: Evaluation of Suspected Anemia.

FP essentials, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.